Can I Take Vitamin B12 with Oral Micronized Progesterone?

The Short Answer: No Clinically Significant Interaction Exists

Oral micronized progesterone and vitamin B12 operate through completely separate biological pathways. Progesterone is metabolized by hepatic CYP3A4 and CYP2C19 enzymes, then excreted as glucuronide conjugates [1]. Vitamin B12 is absorbed at the terminal ileum via the intrinsic-factor receptor, transported by transcobalamin II, and stored primarily in the liver, with no involvement of cytochrome P450 enzymes [2].

Because their absorption, distribution, metabolism, and excretion routes do not overlap, no pharmacokinetic collision is expected or documented.

Why the Question Comes Up Anyway

The confusion often traces back to metformin. Women prescribed oral micronized progesterone for endometrial protection during hormone replacement therapy frequently carry a diagnosis of type 2 diabetes or metabolic syndrome, and metformin is among the most commonly co-prescribed drugs in that population. Metformin inhibits ileal calcium-dependent absorption of the vitamin B12-intrinsic factor complex, a mechanism confirmed in a randomized controlled trial by de Jager et al. (N=390) that found metformin produced a statistically significant reduction in B12 levels compared to placebo over 4.3 years (P<0.001) [3].

The American Diabetes Association's 2024 Standards of Care state directly: "Periodic measurement of vitamin B12 levels should be considered in metformin-treated patients, especially in those with peripheral neuropathy or anemia." [4]

So the B12 concern is about metformin, not progesterone. Conflating the two drugs is understandable but clinically inaccurate.

What "No Direct Interaction" Actually Means

"No interaction" does not mean both agents are pharmacologically inert together. It means no peer-reviewed mechanistic or clinical study has identified a situation in which progesterone alters B12 absorption, transport, or utilization, or in which B12 alters progesterone pharmacokinetics. The FDA-approved prescribing information for Prometrium (Besins Healthcare) lists no B12 interaction in its drug-interaction section [5].

How Oral Micronized Progesterone Works in the Body

Absorption and the Peanut Oil Vehicle

Prometrium capsules suspend micronized progesterone in peanut oil. Micronization reduces particle size to below 10 micrometers, which dramatically increases surface area and allows adequate oral bioavailability, something that conventional oral progesterone tablets fail to achieve. Peak serum concentration occurs roughly 2 to 3 hours after ingestion, and taking the capsule with food increases bioavailability by approximately 1.5-fold compared to the fasted state [5].

Hepatic First-Pass and CYP Enzymes

After intestinal absorption, progesterone undergoes substantial first-pass metabolism in the liver. CYP3A4 converts it to 5-alpha-dihydroprogesterone and other metabolites; CYP2C19 also contributes [1]. This is why drugs that inhibit or induce CYP3A4, such as ketoconazole or rifampin, are the interactions Prometrium's prescribing information highlights. Vitamin B12 does not interact with CYP3A4 or CYP2C19 at any physiologically achievable concentration.

Why Bedtime Dosing Is Standard

The sedative and anxiolytic metabolite allopregnanolone is produced during progesterone metabolism. Clinicians typically instruct patients to take Prometrium at bedtime to allow this sedative effect to occur during sleep rather than during working hours [6]. B12 supplements, by contrast, are stimulating for some individuals, which leads some patients to take them in the morning. Taking the two agents at different times of day is fine, but it is not required by any interaction concern.

How Vitamin B12 Works in the Body

Absorption Requires Intrinsic Factor

Dietary B12 is released from food proteins by gastric acid, then binds to intrinsic factor produced by gastric parietal cells. The B12-intrinsic factor complex travels to the terminal ileum, where it binds the cubilin receptor and enters enterocytes [2]. High-dose oral B12 supplements (500 mcg or more) also achieve modest absorption by passive diffusion, independent of intrinsic factor. This passive route is clinically relevant for patients with pernicious anemia or gastric atrophy.

Transport and Storage

After intestinal uptake, B12 binds transcobalamin II for plasma transport to the liver, bone marrow, and other tissues. The liver stores 2 to 5 mg of B12, enough for approximately 3 to 5 years of normal metabolic needs if dietary intake stops entirely [2]. This long half-life means that B12 deficiency develops slowly, which is why annual monitoring is usually sufficient for at-risk patients.

Roles in Neurological and Hematological Function

B12 is a cofactor for methionine synthase (which remethylates homocysteine to methionine) and methylmalonyl-CoA mutase (which converts methylmalonyl-CoA to succinyl-CoA in the mitochondria) [2]. Deficiency causes megaloblastic anemia and subacute combined degeneration of the spinal cord, an irreversible neuropathy if untreated. Elevated serum homocysteine and methylmalonic acid are earlier biomarkers of functional deficiency than low serum B12 alone.

The Metformin Connection: Where the Real Risk Lives

Prevalence of Metformin-Induced B12 Depletion

Up to 30% of patients on long-term metformin therapy develop subnormal serum B12 levels, according to data cited in the ADA's Standards of Care [4]. The risk increases with duration of use and higher doses. In the de Jager RCT, mean serum B12 fell by 19% in the metformin group versus placebo over 4.3 years [3].

Women using oral micronized progesterone for HRT who also take metformin for diabetes or insulin resistance are therefore at genuine risk for progressive B12 depletion. That risk comes from metformin alone, but progesterone prescribers should ask about metformin co-use at every HRT review appointment.

Clinical Signs to Watch For

Early B12 deficiency is often asymptomatic. As levels fall below roughly 200 pg/mL, patients may notice peripheral tingling, numbness in the feet, fatigue, or cognitive slowing. A study published in the Annals of Internal Medicine found that neurological symptoms of B12 deficiency could precede hematological changes, meaning a normal complete blood count does not rule out neuropathy risk [7].

Prescribers should not wait for macrocytic anemia to appear before checking B12 in a patient on long-term metformin.

Recommended Monitoring Protocol

The following monitoring framework is used by the HealthRX clinical team for patients on oral micronized progesterone who also take metformin:

• Baseline: Serum B12, methylmalonic acid, and homocysteine at HRT initiation if metformin has been used for more than 12 months.
• Annual: Serum B12 at each HRT annual review. Add methylmalonic acid if B12 falls below 300 pg/mL.
• Supplementation threshold: Oral B12 supplementation (1,000 mcg/day methylcobalamin or cyanocobalamin) initiated when serum B12 falls below 300 pg/mL, or immediately if neurological symptoms are present regardless of serum level.
• Intramuscular option: For patients with confirmed malabsorption or serum B12 below 200 pg/mL with symptoms, intramuscular hydroxocobalamin 1,000 mcg weekly for 4 weeks then monthly is preferred over oral supplementation alone.

Pharmacokinetic Analysis: Why Separation Is Not Required

Some patients ask whether they need to separate the timing of their Prometrium dose and their B12 supplement by several hours, as they might with, say, thyroid hormone and calcium. The answer is no. Dose separation is indicated when two agents compete for the same intestinal transporter, chelate each other in the gut lumen, or when one drug significantly alters gastric pH in a way that affects the other's absorption.

None of those conditions apply here. Progesterone is absorbed in the small intestine via passive lipophilic diffusion, facilitated by the peanut oil vehicle. B12 is absorbed in the terminal ileum via receptor-mediated endocytosis (or passive diffusion at high doses). The two molecules do not interact in the gastrointestinal lumen, and neither alters the pH environment needed for the other [2][5].

A pharmacokinetics review published in Clinical Pharmacokinetics confirmed that micronized progesterone's absorption is primarily driven by its lipophilic character and particle size, with no known interactions with water-soluble vitamins in the intestinal compartment [1].

Safety Profile of Combining Oral Micronized Progesterone and B12 Supplements

Evidence From the Postmenopausal HRT Literature

The PEPI Trial (Postmenopausal Estrogen/Progestin Interventions, N=875) examined oral micronized progesterone alongside conjugated equine estrogen and found no safety signals attributable to micronutrient co-administration over 3 years [8]. While PEPI did not specifically track B12 supplementation, none of the adverse events documented in the trial suggested any interaction pathway involving water-soluble vitamins.

The Women's Health Initiative Memory Study also used medroxyprogesterone rather than micronized progesterone, but its broad adverse-event reporting across thousands of participant-years similarly generated no signal involving B12 or other water-soluble vitamins and progestin co-administration [9].

B12 Toxicity Risk

Vitamin B12 has no established tolerable upper intake level because excess is excreted renally with no known toxicity at supplemental doses [2]. Even at 5,000 mcg/day, no adverse effects have been documented in healthy adults. This wide safety margin means there is no dose at which standard B12 supplementation would create a concern when added to Prometrium therapy.

Special Populations

Patients with renal impairment: Progesterone metabolites are partly renally cleared, and B12 excretion is renal. Neither agent accumulates to toxic levels in moderate renal impairment, but both warrant monitoring in stage 4 to 5 chronic kidney disease. The Kidney Disease Improving Global Outcomes (KDIGO) guidelines do not list either agent as contraindicated in CKD, though individual clinical assessment is appropriate [10].

Patients taking proton pump inhibitors: PPIs reduce gastric acid, which impairs B12 release from food proteins. A patient on Prometrium plus a PPI plus metformin carries triple risk for B12 depletion, with all three risk factors being independent of progesterone itself. The FDA issued a drug safety communication noting that long-term PPI use may cause hypomagnesemia and is associated with B12 deficiency [11].

What to Tell Your Prescriber

Bringing a complete supplement list to every HRT appointment is standard practice endorsed by the Endocrine Society's clinical practice guidelines for menopause management [12]. For B12 specifically, the conversation should include:

• Current dose and form of B12 (cyanocobalamin vs. Methylcobalamin, tablet vs. Sublingual vs. Injection)
• Whether metformin is being used concurrently and at what dose
• Any symptoms of peripheral neuropathy, fatigue, or cognitive change
• Date of last serum B12 measurement

The Menopause Society (formerly NAMS) 2022 position statement on hormone therapy notes that concurrent medication review should address all supplements, particularly those affecting neurological health, given that some HRT-eligible patients are in age groups where B12 deficiency prevalence rises naturally to 6% in adults over 60 and 20% in adults over 80 [6][13].

Practical Dosing and Timing Summary

Patients who want clear, practical instructions can follow this pattern without any clinical concern:

• Take Prometrium 100 mg or 200 mg at bedtime with a small snack, as directed by your prescriber.
• Take your B12 supplement at whatever time of day you prefer. Morning is common because some people notice increased energy.
• No minimum separation window between the two agents is required.
• If you also take metformin, discuss annual serum B12 monitoring with your prescriber.
• Sublingual methylcobalamin 1,000 mcg/day is a reasonable choice for patients on metformin, as it bypasses any gastric acid or intrinsic-factor limitations.

Annual serum B12 testing costs roughly $25, $50 without insurance and is included in many standard metabolic panels.